Please enable JavaScript to continue using this application.

Compare $INO vs $TNYA | Chartloom

Compare

$INO vs $TNYA

Inovio Pharmaceuticals Inc · Tenaya Therapeutics Inc

INO

Inovio Pharmaceuticals Inc

TNYA

Tenaya Therapeutics Inc

Compare $INO vs $TNYA

Comparing Inovio Pharmaceuticals Inc and Tenaya Therapeutics Inc

INOInovio Pharmaceuticals Inc

TNYATenaya Therapeutics Inc

INOInovio Pharmaceuticals Inc

Market cap

$95M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

2.48x

Rev growth (TTM)

-100.0%

YTD performance

-32.0%

52W performance

-55.1%

FCF yield

-85.4%

TNYATenaya Therapeutics Inc

Market cap

$126M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

20.11x

Rev growth (TTM)

—

YTD performance

-21.0%

52W performance

-68.3%

FCF yield

-41.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

INO

TNYA

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

INO$95M

TNYA$126M

Enterprise Value

INO$63M

TNYA$48M

Price

INO$1.15

TNYA$0.58

P/E Ratio

INON/A

TNYAN/A

P/S Ratio

INO423.69x

TNYA94.33x

EV/Sales

INO312.32x

TNYA35.84x

EV/EBITDA

INO0.00x

TNYA0.00x

P/B Ratio

INO27.44x

TNYA1.82x

P/FCF Ratio

INON/A

TNYAN/A

EV/FCF

INO-0.78x

TNYA-0.91x

PEG Ratio

INON/A

TNYAN/A

Forward P/E (NTM)

INON/A

TNYAN/A

Forward P/S (NTM)

INO2.48x

TNYA20.11x

Revenue (TTM)

INO$0

TNYA$1M

Revenue Growth (YoY)

INO-100.0%

TNYAN/A

Forward Rev Growth

INO7491.0%

TNYA-49.9%

Gross Margin (TTM)

INO58.9%

TNYA0.0%

Operating Margin (TTM)

INO0.0%

TNYA0.0%

EBITDA Margin (TTM)

INO0.0%

TNYA-5657.2%

Net Margin (TTM)

INO0.0%

TNYA-7724.0%

FCF Margin (TTM)

INON/A

TNYA-3939.2%

Net Income (TTM)

INO$-67M

TNYA$-103M

FCF (TTM)

INO$-81M

TNYA$-53M

EPS (TTM)

INO-$0.83

TNYA-$0.47

ROE (TTM)

INO-19050.0%

TNYA-10805.0%

ROA (TTM)

INO-11105.0%

TNYA-8584.0%

ROIC (TTM)

INO-19050.0%

TNYA-10805.0%

Cash

INO$32M

TNYA$78M

Debt

INO$0

TNYA$0

Net Cash/Debt

INO$32M

TNYA$78M

Current Ratio (TTM)

INO1.00x

TNYA4.52x

Quick Ratio (TTM)

INO0.92x

TNYA4.34x

Debt/Equity (TTM)

INO0.00x

TNYA0.00x

Debt/Assets (TTM)

INO0.0%

TNYA0.0%

Interest Coverage (TTM)

INON/A

TNYAN/A

Net Debt/EBITDA (TTM)

INO0.00x

TNYA0.00x

Beta

INO1.68

TNYA2.87

52W Performance

INO-55.1%

TNYA-68.3%

YTD Performance

INO-32.0%

TNYA-21.0%

% from 52W High

INO-57.7%

TNYA-75.3%

% from 52W Low

INO104.2%

TNYA11.4%

Asset Turnover (TTM)

INO0.00x

TNYA0.00x

FCF Yield (TTM)

INO-85.4%

TNYA-41.8%

Earnings Yield (TTM)

INO-71.3%

TNYA-81.9%

Dividend Yield (TTM)

INON/A

TNYAN/A

Rule of 40

INO-100.0

TNYA-3,939.2

EV/GP/RG

INON/A

TNYAN/A

Ticker research

View INO research View TNYA research

Metric	INO Inovio Pharmaceuticals Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$95M	$126M
Enterprise Value	$63M	$48M
Price	$1.15	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	94.33x
EV/Sales	312.32x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	20.11x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	7491.0%	-49.9%
Profitability
Gross Margin (TTM)	58.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5657.2%
Net Margin (TTM)	0.0%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-67M	$-103M
FCF (TTM)	$-81M	$-53M
EPS (TTM)	-$0.83	-$0.47
ROE (TTM)	-19050.0%	-10805.0%
ROA (TTM)	-11105.0%	-8584.0%
ROIC (TTM)	-19050.0%	-10805.0%
Financial Health
Cash	$32M	$78M
Debt	$0	$0
Net Cash/Debt	$32M	$78M
Current Ratio (TTM)	1.00x	4.52x
Quick Ratio (TTM)	0.92x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.87
52W Performance	-55.1%	-68.3%
YTD Performance	-32.0%	-21.0%
% from 52W High	-57.7%	-75.3%
% from 52W Low	104.2%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-85.4%	-41.8%
Earnings Yield (TTM)	-71.3%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View TNYA research

Valuation

P/S Ratio

TNYA

94.33x

INO

423.69x

EV/FCF

TNYA

-0.91x

INO

-0.78x

Growth & revenue

Revenue Growth TTM

INO

-100.0%

Forward Revenue Growth

INO

7491.0%

TNYA

-49.9%

Profitability & performance

Gross Margin

INO

58.9%

TNYA

0.0%

ROE

TNYA

-10805.0%

INO

-19050.0%

FCF Yield %

TNYA

-41.8%

INO

-85.4%

52-Week Performance

INO

-55.1%

TNYA

-68.3%

Detailed metrics comparison

INO

Inovio Pharmaceuticals Inc

TNYA

Tenaya Therapeutics Inc

Market Cap

INO$95M

TNYA$126M

Enterprise Value

INO$63M

TNYA$48M

Price

INO$1.15

TNYA$0.58

P/E Ratio

INON/A

TNYAN/A

P/S Ratio

INO423.69x

TNYA94.33x

EV/Sales

INO312.32x

TNYA35.84x

EV/EBITDA

INO0.00x

TNYA0.00x

P/B Ratio

INO27.44x

TNYA1.82x

P/FCF Ratio

INON/A

TNYAN/A

EV/FCF

INO-0.78x

TNYA-0.91x

PEG Ratio

INON/A

TNYAN/A

Forward P/E (NTM)

INON/A

TNYAN/A

Forward P/S (NTM)

INO2.48x

TNYA20.11x

Revenue (TTM)

INO$0

TNYA$1M

Revenue Growth (YoY)

INO-100.0%

TNYAN/A

Forward Rev Growth

INO7491.0%

TNYA-49.9%

Gross Margin (TTM)

INO58.9%

TNYA0.0%

Operating Margin (TTM)

INO0.0%

TNYA0.0%

EBITDA Margin (TTM)

INO0.0%

TNYA-5657.2%

Net Margin (TTM)

INO0.0%

TNYA-7724.0%

FCF Margin (TTM)

INON/A

TNYA-3939.2%

Net Income (TTM)

INO$-67M

TNYA$-103M

FCF (TTM)

INO$-81M

TNYA$-53M

EPS (TTM)

INO-$0.83

TNYA-$0.47

ROE (TTM)

INO-19050.0%

TNYA-10805.0%

ROA (TTM)

INO-11105.0%

TNYA-8584.0%

ROIC (TTM)

INO-19050.0%

TNYA-10805.0%

Cash

INO$32M

TNYA$78M

Debt

INO$0

TNYA$0

Net Cash/Debt

INO$32M

TNYA$78M

Current Ratio (TTM)

INO1.00x

TNYA4.52x

Quick Ratio (TTM)

INO0.92x

TNYA4.34x

Debt/Equity (TTM)

INO0.00x

TNYA0.00x

Debt/Assets (TTM)

INO0.0%

TNYA0.0%

Interest Coverage (TTM)

INON/A

TNYAN/A

Net Debt/EBITDA (TTM)

INO0.00x

TNYA0.00x

Beta

INO1.68

TNYA2.87

52W Performance

INO-55.1%

TNYA-68.3%

YTD Performance

INO-32.0%

TNYA-21.0%

% from 52W High

INO-57.7%

TNYA-75.3%

% from 52W Low

INO104.2%

TNYA11.4%

Asset Turnover (TTM)

INO0.00x

TNYA0.00x

FCF Yield (TTM)

INO-85.4%

TNYA-41.8%

Earnings Yield (TTM)

INO-71.3%

TNYA-81.9%

Dividend Yield (TTM)

INON/A

TNYAN/A

Rule of 40

INO-100.0

TNYA-3,939.2

EV/GP/RG

INON/A

TNYAN/A

Ticker research

View INO research View TNYA research

Metric	INO Inovio Pharmaceuticals Inc	TNYA Tenaya Therapeutics Inc
Market & Valuation
Market Cap	$95M	$126M
Enterprise Value	$63M	$48M
Price	$1.15	$0.58
P/E Ratio	N/A	N/A
P/S Ratio	423.69x	94.33x
EV/Sales	312.32x	35.84x
EV/EBITDA	0.00x	0.00x
P/B Ratio	27.44x	1.82x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.78x	-0.91x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	2.48x	20.11x
Revenue & Growth
Revenue (TTM)	$0	$1M
Revenue Growth (YoY)	-100.0%	N/A
Forward Rev Growth	7491.0%	-49.9%
Profitability
Gross Margin (TTM)	58.9%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-5657.2%
Net Margin (TTM)	0.0%	-7724.0%
FCF Margin (TTM)	N/A	-3939.2%
Net Income (TTM)	$-67M	$-103M
FCF (TTM)	$-81M	$-53M
EPS (TTM)	-$0.83	-$0.47
ROE (TTM)	-19050.0%	-10805.0%
ROA (TTM)	-11105.0%	-8584.0%
ROIC (TTM)	-19050.0%	-10805.0%
Financial Health
Cash	$32M	$78M
Debt	$0	$0
Net Cash/Debt	$32M	$78M
Current Ratio (TTM)	1.00x	4.52x
Quick Ratio (TTM)	0.92x	4.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.68	2.87
52W Performance	-55.1%	-68.3%
YTD Performance	-32.0%	-21.0%
% from 52W High	-57.7%	-75.3%
% from 52W Low	104.2%	11.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-85.4%	-41.8%
Earnings Yield (TTM)	-71.3%	-81.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-100.0	-3,939.2
EV/GP/RG	N/A	N/A
Ticker research	View INO research	View TNYA research